Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00411788
Status:
COMPLETED
Last Update Posted:
2016-09-21
First Post:
2006-12-14
Brief Title:
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Sponsor:
Yale University
Organization:
Yale University